comparemela.com
Home
Live Updates
AIM ImmunoTech Announces Publication of Positive Findings fr
AIM ImmunoTech Announces Publication of Positive Findings fr
AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research
Data demonstrate compelling evidence of the immune-stimulatory properties linked to TLR-3 activation through AmpligenOCALA, Fla., March 25, 2024 -- AIM ImmunoTech Inc. today announced the...
Related Keywords
United States ,
American ,
Thomask Equels ,
,
Facebook ,
Exchange Commission ,
Immunotech Inc ,
Erasmus University Medical Center ,
Early Access Program ,
Linkedin ,
Astrazeneca ,
Clinical Cancer Research ,
Advanced Pancreatic Cancer ,
Anti Tumor Immunity ,
Dendritic Cell Mediatedt Responses ,
Executive Officer Thomas ,
Pancreato Biliary Surgeon ,
Private Securities Litigation Reform Act ,
Markets ,